COVID Jab Safe In Adolescents, Children With MIS-C: Study

As per the latest COVID News, scientists have now established the fact that COVID jab is safe among children and adolescents who have the problem of multisystem inflammatory syndrome (MIS-C).

And so, it is safe for them to get COVID-19 vaccine even after they have the said complication.

The research carried out by them revealed that they had no serious complication like MIS-C reoccurrence or myocarditis even after administering the COVID-19 vaccine.


COVID Jab Safe In Adolescents, Children With MIS-C: Study

Among those tested for the above, half of them were found to experience typical and mild reactions like fatigue and arm soreness.

Please note that MIS-C is still a poorly understood condition affecting one in 4000 children.

The condition also affects adolescents who earlier had COVID-19, as reported by the Centre for Disease Control and Prevention (CDC). The issue has been found to occur after a few weeks of COVID infection which may lead to organ failure.

MIS-C have a wide range of symptoms like fever, stomach pain, inflammation of the heart muscle. It can also lead to a serious condition called myocarditis.

The sad part is that there are no known cause of MIS-C. But there are certain medications that can help reduce the inflammation that are linked to damage the organs.

There are some healthcare professionals who are curious to know if COVID-19 vaccines are responsible to cause a serious and adverse reaction in those having a history of MIS-C, but there is not much data to explain this.

“In light of the acute and long-term consequences of COVID-19 it is vital to continue the development, testing, and deployment of preventive as well as therapeutic agents in at-risk groups as well as the general population,” said Gary H. Gibbons, director of NHLBI, part of NIH.

To date, more than 9,000 patients have been diagnosed with MIS-C in the United States, and 74 have died, according to data from the CDC. However, the disease appears to be on the decline, according to studies by others, the study said.

“A big part of that decline is that COVID vaccination has been protective against this rare condition in those who have received it,” Dionne said.






Leave a Comment

Scroll to Top